Clinical Trials

Sponsor(s): Fudan University

Condition(s):

Colon Cancer
Colorectal Cancer
Colorectal Carcinoma
Liver Cancer
Liver Metastases
Rectal Cancer
Liver Tumor
Cancer
Liver Disease
Gastrointestinal Diseases and Disorders
Metastatic Cancer
Neoplasms
Rectal Disorders

Purpose: The purpose of this study is to investigate whether preoperative TAC is able to improve progression free survival and overall survival in patients receiving liver metastasis resection of colorectal cancer.

Eligibility:

Minimum Age:

18 Years

Maximum Age:

75 Years

Accepts Healthy Volunteers:

No

Inclusion Criteria:

- age <= 75 years

- resectable liver metastasis

- remnant liver volume >= 70%

- without other organ metastasis or peritoneum metastasis

- without contradiction of cardiac and pulmonary diseases

Exclusion Criteria:

- age > 75 years

- unresectable liver metastasis

- remnant liver volume < 50%

- with other organ metastasis or peritoneum metastasis

- with contradiction of cardiac and pulmonary diseases

Other Location(s): shanghai, China

Terms: This is an abstract courtesy of ClinicalTrials.gov, a service of the US National Institute of Health Developed by the National Library of Medicine. ClinicalTrials.gov provides regularly updates information about federally and privately supported clinical research in human volunteers.